ABBV
Price
$294.88Alerts
Change
+$0.99 (+0.34%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
514.78B
84 days until earnings call
Intraday BUY SELL Signals
MEDI
Price
$36.18Alerts
Change
+$0.09 (+0.25%)
Updated
Nov 11, 03:14 PM (EDT)
Net Assets
41.78M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABBV vs MEDI

ABBV vs MEDI Comparison Chart in %
View a ticker or compare two or three
VS
ABBV vs. MEDI commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Hold and MEDI is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ABBV with price predictions
Nov 10, 2026

Aroon Indicator for ABBV shows an upward move is likely

ABBV's Aroon Indicator triggered a bullish signal on November 10, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 352 similar instances where the Aroon Indicator showed a similar pattern. In 225 of the 352 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on ABBV as a result. In 48 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

Following a +0.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABBV advanced for three days, in 221 of 360 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

Bearish Trend Analysis

The 10-day RSI Indicator for ABBV moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 17 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 40%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 69 cases where ABBV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 43%.

The Moving Average Convergence Divergence Histogram (MACD) for ABBV turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 22 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 46%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.

ABBV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (-86.736) is very low in comparison to the industry average of (-1.421). ABBV has a moderately high P/E Ratio (82.291) as compared to the industry average of (21.700). Projected Growth (PEG Ratio) (0.544) is also within normal values, averaging (5.738). Dividend Yield (0.024) settles around the average of (0.038) among similar stocks. ABBV's P/S Ratio (7.231) is slightly higher than the industry average of (4.033).

The Tickeron Price Growth Rating for this company is 11 (best 1 - 100 worst), indicating outstanding price growth. ABBV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for MEDI with price predictions
Nov 10, 2026

MEDI in upward trend: 10-day moving average broke above 50-day moving average on October 29, 2026

The 10-day moving average for MEDI crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on MEDI as a result. In 67 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for MEDI just turned positive on October 15, 2026. Looking at past instances where MEDI's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.

MEDI moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where MEDI advanced for three days, in 185 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 153 of 169 cases where MEDI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for MEDI moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 18 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEDI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

MEDI broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

FUNDAMENTALS RATINGS
ABBV: Fundamental Ratings
ABBV
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
2
SMR RATING
1..100
1
PRICE GROWTH RATING
1..100
11
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABBVMEDI
RSI
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
46%
Bearish Trend 10 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
37%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ABBV: $293.89)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 4 FA rating(s) are green while .

  • ABBV’s FA Score: 4 green, 1 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 3 TA indicator(s) are bullish.

  • ABBV’s TA Score: 3 bullish, 5 bearish.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +2.76% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.33%. For the same industry, the average monthly price growth was +2.53%, and the average quarterly price growth was +7.15%.

Reported Earning Dates

ABBV is expected to report earnings on Feb 03, 2027.

Industries' Descriptions

@Pharmaceuticals: Major (-1.33% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
Interact to see
Advertisement

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with NVS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+0.20%
NVS - ABBV
52%
Loosely correlated
-0.26%
JNJ - ABBV
51%
Loosely correlated
-0.47%
BMY - ABBV
50%
Loosely correlated
+1.06%
AMGN - ABBV
49%
Loosely correlated
N/A
GILD - ABBV
47%
Loosely correlated
+0.92%
More

MEDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEDI has been closely correlated with LLY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if MEDI jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDI
1D Price
Change %
MEDI100%
-0.05%
LLY - MEDI
68%
Closely correlated
+1.44%
ABBV - MEDI
53%
Loosely correlated
+0.20%
MRK - MEDI
50%
Loosely correlated
-0.48%
PFE - MEDI
48%
Loosely correlated
+0.44%
TECH - MEDI
47%
Loosely correlated
-0.01%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NOG23.410.52
+2.27%
Northern Oil and Gas
SMMT17.83-0.01
-0.06%
Summit Therapeutics
VTVT21.00-0.18
-0.85%
vTv Therapeutics
NRDS7.42-0.40
-5.12%
NerdWallet
BDMD0.10-0.02
-13.70%
Baird Medical Investment Holdings Ltd